share_log

Yatsen | 6-K: Report of foreign private issuer (related to financial reporting)

Yatsen | 6-K: Report of foreign private issuer (related to financial reporting)

逸仙电商 | 6-K：外国发行人报告（业绩相关）
美股SEC公告 ·  2024/11/20 06:07

Moomoo AI 已提取核心信息

Yatsen reported Q3 2024 total net revenues of RMB677.0 million ($96.5M), down 5.7% YoY, while skincare brands revenue grew 3.6% to RMB267.9 million. Gross margin improved to 75.9% from 71.4% in the prior year period, driven by increased sales of higher-margin products. Net loss narrowed to RMB121.1 million from RMB197.9 million YoY.Operating expenses decreased 12.0% YoY to RMB655.2 million, with general and administrative expenses showing significant improvement. The company's three major clinical and premium skincare brands, including Galénic, DR.WU and Eve Lom, delivered solid performance with combined growth of 10.5% YoY, despite challenges in China's beauty industry.For Q4 2024, Yatsen expects total net revenues between RMB1.07 billion and RMB1.18 billion, representing a YoY increase of approximately 0% to 10%. The company maintains focus on enhancing brand equity, optimizing product mix and cost structure to drive sustainable growth.
Yatsen reported Q3 2024 total net revenues of RMB677.0 million ($96.5M), down 5.7% YoY, while skincare brands revenue grew 3.6% to RMB267.9 million. Gross margin improved to 75.9% from 71.4% in the prior year period, driven by increased sales of higher-margin products. Net loss narrowed to RMB121.1 million from RMB197.9 million YoY.Operating expenses decreased 12.0% YoY to RMB655.2 million, with general and administrative expenses showing significant improvement. The company's three major clinical and premium skincare brands, including Galénic, DR.WU and Eve Lom, delivered solid performance with combined growth of 10.5% YoY, despite challenges in China's beauty industry.For Q4 2024, Yatsen expects total net revenues between RMB1.07 billion and RMB1.18 billion, representing a YoY increase of approximately 0% to 10%. The company maintains focus on enhancing brand equity, optimizing product mix and cost structure to drive sustainable growth.
逸仙电商公布了2024年第三季度总净营业收入为人民币67700万（96.5百万美元），同比下降5.7%，而护肤品牌的营业收入增长了3.6%至人民币26790万。毛利率从去年同期的71.4%提高至75.9%，这是由于高毛利产品销量的增加。净亏损同比缩减至人民币12110万，较去年的人民币19790万减少。营业费用同比减少12.0%，降至人民币65520万，一般和管理费用显著改善。尽管中国的美容行业面临挑战，公司旗下三大临床和高端护肤品牌，包括Galénic、DR.WU和Eve Lom，交出了10.5%的同比增长的良好业绩。对于2024年第四季度，逸仙电商预计总净营业收入在人民币10.7亿到人民币11.8亿之间，同比增长约为0%到10%。公司继续专注于提升品牌价值，优化产品组合和成本结构，以推动可持续增长。
逸仙电商公布了2024年第三季度总净营业收入为人民币67700万（96.5百万美元），同比下降5.7%，而护肤品牌的营业收入增长了3.6%至人民币26790万。毛利率从去年同期的71.4%提高至75.9%，这是由于高毛利产品销量的增加。净亏损同比缩减至人民币12110万，较去年的人民币19790万减少。营业费用同比减少12.0%，降至人民币65520万，一般和管理费用显著改善。尽管中国的美容行业面临挑战，公司旗下三大临床和高端护肤品牌，包括Galénic、DR.WU和Eve Lom，交出了10.5%的同比增长的良好业绩。对于2024年第四季度，逸仙电商预计总净营业收入在人民币10.7亿到人民币11.8亿之间，同比增长约为0%到10%。公司继续专注于提升品牌价值，优化产品组合和成本结构，以推动可持续增长。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Longevity Health Holdings
    XAGE
    -- 0.320
    e.l.f. Beauty
    ELF
    -- 74.040
    朴荷生物科技
    PHH
    -- 8.033
    科蒂
    COTY
    -- 6.020
    Kenvue
    KVUE
    -- 23.920
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    科技巨头财报季如火如荼，英伟达压轴会表现如何？
    星期四， $亚马逊 (AMZN.US)$ 股价在公司报告第四季度调整后每股收益为1.86美元，预估为每股1.50美元，营业收入为1877.9亿，预估为1873.2亿后下跌。该公司预测第一季度的营业收入数字低于华尔街的预期，预测本季度最多为1550亿，而分析师希望为1580亿。 星 展开
    亚马逊盈利预告：猜测开盘价，获取奖励！